(143) The prevalence of broad neuropathic pain in the United States: results from a multi-channel general population health survey

Abstract

essential for providers to identify patients at risk for prolonged opioid use. As a first step, our research identifies significant patient characteristics that may predict prolonged opioid use and associated complications.

Epidemiology of physician-diagnosed neuropathic pain in Brazil

“…A comparison of sample sizes shows that NeP was most frequently identified in middle-aged and Pardo patients. Consistent with a previous US-based study,4 the most frequently diagnosed condition in this study was CLBP-NeP (25.1%), followed by similar rates of pDPN (12.7%), CNP (12.5%), and PTN (11.7%). As has been noted in previous epidemiological research,20 patients reported high rates of comorbid disease and NeP-related symptomatology across all subtypes, most notably high blood pressure and high cholesterol, and areas of numbness and hyperalgesia.…”

“…As has been noted in previous epidemiological research,20 patients reported high rates of comorbid disease and NeP-related symptomatology across all subtypes, most notably high blood pressure and high cholesterol, and areas of numbness and hyperalgesia. Once again, and consistent with previous research,4,21–23 the majority of patients across all subtypes reported currently being treated, specifically using prescription NSAIDs, antiepileptics, and opioids to treat their pain. The reliance upon NSAIDs and opioids may stem from patients also managing nociceptive pain, eg, osteoarthritis, which would also be consistent with previous studies 8,21,22,24–26.…”

“…It is a highly prevalent condition that affects a significant proportion of the population. A 2014 systematic review by van Hecke et al3 reported a prevalence rate of 6.9%–10.0% across studies globally, primarily the USA and Europe, with similar rates reported in a separate US-based study by DiBo-naventura et al4 It is possible that these rates underestimate the true prevalence of NeP, as no standardized and accepted diagnostic criteria exist for this condition, leading to possible underdiagnosis and undertreatment 5…”

Diagnoses and Approaches to Patients With Neurotic Pain

“…Она затрагивает миллионы людей во всем мире, и примерная ее распространенность среди населения в целом достигает 7-8% [6,7]. Исследование, проведенное в США в 2015 г. с использованием опросни-ка Pain Detect среди 25000 взрослых американцев, пока-зало, что примерно 64% респондентов испытывали боле-вой синдром, и у 10% обследованных он соответствовал критериям НБ [8]. Обычно НБ является хроническим, тяжелым состоянием, и резистентна к анальгетикам и нестероидным противовоспалительным препаратам.…”